Influence of antipsychotic drugs on hormone levels - Important side effects to be noted;Antipsykotika kan påverka hormonbalansen: Viktökning, blodlipidrubbningar och diabetes viktiga biverkningar

Lakartidningen

Volumn 98, Issue 48, 2001, Pages 5462-5469

  Melkersson, Kristina ^a,c   Hulting, Anna Lena ^b  

^a Riksforbundet Social Mental Halsa   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Sollentuna Psychiatric Polyclinic   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; HUMAN GROWTH HORMONE; INSULIN; LIPID; NEUROLEPTIC AGENT; PROLACTIN; SOMATOMEDIN C;

BLOOD; DIABETES MELLITUS; DRUG EFFECT; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERPROLACTINEMIA; IATROGENIC DISEASE; MALE; REVIEW; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; DIABETES MELLITUS; ENGLISH ABSTRACT; FEMALE; HUMAN; HUMAN GROWTH HORMONE; HYPERLIPIDEMIA; HYPERPROLACTINEMIA; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LIPIDS; MALE; PROLACTIN; WEIGHT GAIN;

EID: 0035965824     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999;156:1686-96.
2. Osser DN, Najarian DM, Dufresne RL. Olanzapine increases weight and serum triglyceride levels. J Clin Psychiatry 1999;60:707-70.
3. Henderson DC, Cagliero E, Gray C, Nasrallah RA, Hayden DL, Schoenfeld DA, et al. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study. Am J Psychiatry 2000;157:975-81.
4. Dickson RA, Dalby JT, Williams R, Edwards AL. Risperidone-induced prolactin elevations in premenopausal women with schizophrenia [letter]. Am J Psychiatry 1995;152:1102-3.
5. Shiwach RS, Carmody TJ. Prolactogenic effects of risperidone in male patients - a preliminary study. Acta Psychiatr Scand 1998;98:81-93.
6. Melkersson K, Hulting AL, Hall K. Hormonal evaluation in schizophrenic patients treated with neuroleptics. Neuroendocrinology Letters 1999;20:199-204.
7. Melkersson K, Hulting AL, Rane A. Dose requirement and prolactin elevation of antipsychotics in male and female patients with schizophrenia or related psychoses. Br J Clin Pharmacol 2001;51:317-24.
8. Melkersson K, Hulting AL. Prolactin-secreting pituitary adenoma in neuroleptic treated patients with psychotic disorder. Eur Arch Psychiatry Clin Neurosci 2000;250:6-10.
9. Rosen T, Bosaeus I, Tölli J, Lindstedt G, Bengtsson BÅ. Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency. Clin Endocrinol 1993;38:63-71.
10. Rosen T. Effects on cardiovascular risk factors. In: Juul A, Jørgensen JOL, editors. Growth hormone in adults: Physiological and clinical aspects, 1st ed. New York, NY: Cambridge University Press; 1996, p. 283-94.
11. Nair NP, Lal S, Cervantes P, Yassa R, Guyda H. Effect of clozapine on apomorphine-induced growth hormone secretion and serum prolactin concentrations in schizophrenia. Neuropsychobiology 1979; 5:136-42.
12. Meltzer HY. Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia. Psychopharmacology 1989;99:18-27.
13. Melkersson KI, Hulting AL, Brismar KE. Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses. J Clin Psychiatry 1999;60:783-91.
14. Melkersson K. Influence of antipsychotic drugs on hormone levels [dissertation]. Stockholm: Karolinska Institute, Sweden, 2000.
15. Hägg S, Joelsson L, Mjörndal T, Spigset O, Oja G, Dahlqvist R. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications. J Clin Psychiatry 1998;59: 294-9.
16. Melkersson KI, Hulting AL, Brismar KE. Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. J Clin Psychiatry 2000;61:742-9.
17. Yazici KM, Erbas T, Yazici AH. The effect of clozapine on glucose metabolism. Exp Clin Endocrinol Diabetes 1998;106:475-7.
18. Melkersson K, Hulting AL. Insulin and leptin levels in patients with schizophrenia or related psychoses - a comparison between different antipsychotic agents. Psychopharmacology 2001;154:205-12.
19. Brömel T, Blum WF, Ziegler A, Schulz E, Bender M, Fleischhaker C, et al. Serum leptin levels increase rapidly after initiation of clozapine therapy. Mol Psychiatry 1998;3:76-80.
20. Kraus T, Haack M, Schuld A, Hinze-Seich D, Kühn M, Uhr M, et al. Body weight and leptin plasma levels during treatment with antipsychotic drugs. Am J Psychiatry 1999;156:312-4.